| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Anatomy | View |
| None | Anxiety | View |
| None | Atrophic | View |
| None | Behavioral | View |
| None | Brain | View |
| None | Brain Region | View |
| None | Cephalic | View |
| None | Cognitive | View |
| None | Communities | View |
| None | Dementia | View |
| None | Development | View |
| None | Dose | View |
| None | Double-Blind Method | View |
| None | Electric Stimulation | View |
| None | Enrollment | View |
| None | Evaluation | View |
| None | Exhibits | View |
| None | Exposure to | View |
| None | Frequencies | View |
| None | Future | View |
| None | Gait | View |
| None | Gait Speed | View |
| None | Genetic Crossing Over | View |
| None | Home | View |
| None | Impaired Cognition | View |
| None | Individual | View |
| None | Intervention | View |
| None | Intervention Studies | View |
| None | Magnetic Resonance Imaging | View |
| None | Measurable | View |
| None | Measures | View |
| None | Mood | View |
| None | Motor | View |
| None | Multi-Institutional Clinical Trial | View |
| None | Neuronal Plasticity | View |
| None | Outcome | View |
| None | Participant | View |
| None | Performance | View |
| None | Phase | View |
| None | Pilot Projects | View |
| None | Prefrontal Cortex | View |
| None | Randomized | View |
| None | Randomized Controlled Clinical Trials | View |
| None | Research | View |
| None | Resolution | View |
| None | Rest | View |
| None | Risk | View |
| None | Series | View |
| None | Site | View |
| None | Structure | View |
| None | Testing | View |
| None | Therapeutic | View |
| None | Time | View |
| None | Syndrome | View |
| None | Walking | View |
| None | Work | View |
| None | Arm | View |
| None | cerebral atrophy | View |
| None | Clinically relevant | View |
| None | cognitive task | View |
| None | Cost | View |
| None | Dementia Risk | View |
| None | Design | View |
| None | Executive Function | View |
| None | functional improvement | View |
| None | functional near infrared spectroscopy | View |
| None | Gray Matter | View |
| None | high risk | View |
| None | home test | View |
| None | improved | View |
| None | insight | View |
| None | late life | View |
| None | mental function | View |
| None | neural network | View |
| None | neuroimaging | View |
| None | noninvasive brain stimulation | View |
| None | normal aging | View |
| None | older adult | View |
| None | older men | View |
| None | older women | View |
| None | open label | View |
| None | primary endpoint | View |
| None | response | View |
| None | secondary outcome | View |
| None | smartphone application | View |
| None | transcranial direct current stimulation | View |
| None | trial design | View |
| None | walking speed | View |
| None | Alzheimer's Disease | View |